In conclusion, (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol could inhibit cell growth of colon cancer in vivo and in vitro through activation of Fas, DR3 and inhibition of STAT3 and NF-κB pathways. The gene discussed is NFKB1; the disease is colonic neoplasm.